60 minutes. The resulting gradient fractions were drawn off, using a suction apparatus, and saved for isotope and protein determinations.
The radioactive counting procedure was as follows: 0.7 ml of the sample wa.s drawn into a new 1 ml plastic serological pipette, 0.2 ml were drained into a 13 X 100 mm tube and frozen for protein assay. The remaining 0.5 ml was washed into a counting vial with a minipet containing 2.5 ml H20. Then, 13 ml of the -I-T21 Fluor (toluene ;-PPO-:-POPOP-+-Triton X-lOO) was added to each vial so that a total vial volume could be made up to 16 ml. The tubes were tightly capped, thoroughly shaken, numbered and placed in a Nuclear Chicago Mark 1 Liquid Scintillation Counting System.
Introduction
The injection of chlorpromazinet 60 minutes after mescaline in human subjects produced an abrupt halt in symptoms of the mescaline-induced state (5) but there is no animal data available, on the subcellular distribution of mescaline in this sequence of drug administration. The same result is produced by pre-treatment with chlorpromazine or thioperazinett (10) , and previous experiments in rats (6) suggested that prior treatment with different psychotropic drugs before mescaline was given might affect the latter's uptake in various subcellular fractions. The present study was intended to amplify these findings.
Pairs of white female rats were injected intraperitoneally with either chlorpromazine, thioperazine or diethazinettt, at various dosages (Table I) followed 30 minutes later by intraperitoneal radioactive mescaline-Sv'C HCl (Mallinkrodt-Nuclear), The animals were sacrificed by cervical dislocation 40 minutes later (Table II) . Their brains were removed, rinsed in physiological saline, blotted, thoroughly stripped of blood and membranes and divided into four anatomical sections (12) .
The cerebral cortex from both hemispheres were placed in a 15 ml Tri-R homogenizing tube to which 10 ml of 0.32 M sucrose solution per gram of tissue was added, and then homogenized with seven up and down strokes, repeated one minute later. The homogenate was divided between two 15 ml gradua.ted conical plastic test CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL Protein was determined by a modification of the Lowry method (8) . The purity of mescaline and the homogenate mescaline content were checked by thin layer chromatography, which was done on samples of cold mescaline, syringe wash and brain homogenate after 30 and 60 minutes in the experiments noted below. Radioactivity was determined by cutting spots from the Eastman Chromogram sheet, and following the same procedures for counting as with tissue.
Results
The uptake of radioactive mescaline* * into the whole cortex was decreased by 14 per cent in the animals receiving mescaline followed by chlorpromazine. The 60-minute mescaline group received approximately three times the dose of the other animalssee Table I . Nevertheless, there was only **(ng mescaline/g tissue) (mg dose/IOO g body weight)
one-half as much mescaline present at' that time (60 minutes) in spite of the larger dose. There was a marked increase in radiotracer uptake by the subcellular fractions of the mescaline-chlorpromazine group sacrificed 60 minutes after mescaline when compared to the control animals receiving mescaline alone. While the mescaline homogenate content was similar for both groups, chlorpromazine, given 30 minutes after mescaline, caused a retention of the psychotomimetic in the myelin and nerve ending particle fraction -see Tables III and IV. More mescaline was found in the whole brain after prior injection of either chlorpromazine, thioperazine or diethazinesee Tables III and IlIa. There was a 14.7 per cent increase of mescaline in the diethazine pre-treated brain homogenate, without similar changes for the other two drugs. The prior injection of chlorpromazine or thioperazine produced a 263 per cent inDrug 1 (Neps = nerve ending particle fraction; mito = mitochondrial fraction) crease in radioactive mescaline content of the nerve ending particle fraction, but diethazine caused a 58 per cent decrease.
-see Table III .
The ratio of protein between the S./P.r fractions was approximately equal for the mescaline only and also for the mescalinechlorpromazine groups. The ratio of mg mescaline/mg protein in the S. fraction was one for both groups but in the P.r fraction it was 0.67.
Homogenate activity of mescaline was identified by thin layer chromatography at 30 and 60 minutes after injection of either diethazine-mescaline or mescaline-chlorpromazine. The percentage of counts with an Rf § for mescaline in both experiments dropped from 80 per cent (30 minutes) to 50 per cent (60 minutes), without regard to pre-medication.
.~Rf=O.60-0.~8, in N-butanol, acetic acid, water and silica gel G thin-layer; specific activity = 16.46 mc/mlvl.
Discussion
It is difficult to compare these experiments with previous studies since routes of administration, dosages and weights of animals differed and the specific activities could not be determined from the former investigations. Intravenous administration may influence brain isotope concentration but earlier experiments have not sustained this hypothesis (7) . However, dosage can influence quantitative uptake but the present study confirmed that pre-medication with chlorpromazine or thioperazine increased mescaline uptake into the nerve ending particle fraction, although not in the same proportion as was found previously (6) . This may be a function of dosage differences, and the exact biochemical and biophysical mechanisms remain to be determined.
The administration of diethazine before mescaline produced the most marked in- crease in total brain mescaline content, supporting previous findings in rats (6) as well as clinical studies where patients showed an extraordinary reaction when the diethazinemescaline combination was used (4). Curiously enough, although the diethazine pretreatment homogenate showed increased mescaline radioactivity, the myelin and nerve ending particle fractions showed more than a 50 per cent decrease in isotope concentration. It is possible that the drug was distributed diffusely in the neuropil at that time and not compartmentalized in any fraction. Contrary to chlorpromazine or thioperazine which stabilize membranes ( 11) it is possible that diethazine 'destabilized' the membrane, removing any potential binding sites. The combination of diethazinemescaline appears to be synergestic in its psychotomimetic properties. The dosage of mescaline was increased four times in the second series of experiments (mescaline only and mescaline-chlorpromazine) since the brain concentration reaches a peak at 30 minutes and begins to fall rapidly thereafter (6) . Chlorpromazine does, in effect, produce a small decrease in total brain mescaline content when injected after mescaline. The brain mescaline concentration begins to fall at 30 minutes and it is possible that the decreased whole brain concentration (Table III) noted in the mescaline-chlorpromazine sequence may also be reflecting these metabolic movements. Since the homogenate mescaline content of both groups was similar, the decrease probably reflects changes in the sub-cortical and hind brain areas. There was a redistribution of the tracer in the fractions of the mescaline-chlorpromazine animals, with increases in the myelin and nerve ending particle fractions where more mescaline was being retained. Perhaps the lessened increase of mescaline in mitochondria may be a result of either or both drugs being inactivated in that organelle. The injection of chlorpromazine after mescaline increased the nerve ending particle concentration of the latter drug almost twice that of the chlorpromazine-mescaline sequence. The exact reason for this finding is still obscure.
More mescaline was retained in the crude mitochondrial fraction (P 2r) when chlorpromazine was injected 30 minutes later -see Table V . This suggests that some of the differences in the amounts of mescaline in the gradient fractions were not necessarily due to the stabilization of protein during the separation, since the protein ratios of It is difficult to compare the mescaline biotransformation in rat with other studies (1, 3, 9) because of species, dosage and technique differences. The present findings showing a significant loss of mescaline-Sv''C radioactivity at 60 minutes, coupled with the fact that many mescaline metabolites are inactive (2,3) may indicate that the parent drug (mescaline) is the active compound. It is also of interest that the diethazine premedication did not influence the speed of biotransformation into the different mescaline metabolites. The whole problem of mescaline metabolism at the subcellular level is worthy of further study.
Conclusions
Chlorpromazine or thioperazine pre-treatment before radioactive mescaline in the rat resulted in significant differences in radioisotope uptake into the whole brain and different subcellular fractions when compared to controls. The diethazine-mescaline combination produced a sharp rise in total brain mescaline and a considerable fall in concentration within the myelin and nerve ending particle fractions.
There was an important metabolic transformation of mescaline-8-"C between 30 and 60 minutes in the diethazine-mescaline and mescaline-chlorpromazine groups as determined by thin layer chromatography.
